Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact by Mark Eisenberg 12.02.2024 Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...